Particularly to the lung cancer model, we have shown that activation of the host PAFR (via studies using PAFR-expressing wild type and PAFR-deficient mice) not only augments the growth but also the metastatic ability of murine Lewis lung carcinoma (LLC1) cells [33]. Here, PTAFR is linked to lung carcinoma.